Literature DB >> 24043659

Supervised injection sites: prejudice should not trump evidence of benefit.

Maria Zlotorzynska, Evan Wood, Julio S Montaner, Thomas Kerr.   

Abstract

Mesh：

Year:  2013        PMID： 24043659      PMCID： PMC3796591          DOI： 10.1503/cmaj.130927

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Drug addiction.

Authors:  Jordi Camí; Magí Farré
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

2.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

4.  Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.

Authors:  Thomas Kerr; Mark W Tyndall; Ruth Zhang; Calvin Lai; Julio S G Montaner; Evan Wood
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

5.  A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.

Authors:  Martin A Andresen; Neil Boyd
Journal:  Int J Drug Policy       Date:  2009-05-06

6.  Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

Authors:  D M Patrick; S A Strathdee; C P Archibald; M Ofner; K J Craib; P G Cornelisse; M T Schechter; M L Rekart; M V O'Shaughnessy
Journal:  Int J STD AIDS       Date:  1997-07       Impact factor: 1.359

7.  Use of supervised injection facilities and injection risk behaviours among young drug injectors.

Authors:  María J Bravo; Luis Royuela; Luis De la Fuente; María T Brugal; Gregorio Barrio; Antonia Domingo-Salvany
Journal:  Addiction       Date:  2009-02-10       Impact factor: 6.526

8.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262
  8 in total
  4 in total

1.  Increased drug use and the timing of social assistance receipt among people who use illicit drugs.

Authors:  Emanuel Krebs; Linwei Wang; Michelle Olding; Kora DeBeck; Kanna Hayashi; M-J Milloy; Evan Wood; Bohdan Nosyk; Lindsey Richardson
Journal:  Soc Sci Med       Date:  2016-11-04       Impact factor: 4.634

2.  Ambivalence about supervised injection facilities among community stakeholders.

Authors:  Carol Strike; Tara Marie Watson; Gillian Kolla; Rebecca Penn; Ahmed M Bayoumi
Journal:  Harm Reduct J       Date:  2015-08-21

Review 3.  Supervised injection facilities in Canada: past, present, and future.

Authors:  Thomas Kerr; Sanjana Mitra; Mary Clare Kennedy; Ryan McNeil
Journal:  Harm Reduct J       Date:  2017-05-18

4.  A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.

Authors:  Ehsan Jozaghi; Andrew A Reid; Martin A Andresen; Alexandre Juneau
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.